Biogen Inc. (BIIB) Stock Analysis

Biogen Inc.
$256.14
+3.14% today
Market Cap
$37.86B
Sector
Healthcare
Last Updated
November 09, 2026

BIIB Stock Analysis Overview

Get comprehensive analysis of Biogen Inc. (BIIB) stock with our professional-grade research platform. Our analysis combines DCF valuation models with AI-powered predictions to give you the complete picture.

Biogen Inc. is a Healthcare company with a market capitalization of $37.86 billion. Currently trading at $256.14, the stock is up 3.14% today.

What's Included in Our BIIB Analysis

View Complete BIIB Analysis →

More BIIB Resources

Why Analyze Biogen Inc. Stock?

Biogen Inc. (BIIB) represents a significant investment opportunity in the Healthcare sector. Understanding the company's financial health, valuation metrics, and growth prospects is essential for making informed investment decisions.

Our analysis provides institutional-grade research typically reserved for professional investors, now available for free. We update BIIB data daily to ensure you have the most current information for your investment decisions.

← Back to Home